About Sharon Bio-Medicine
Sharon Bio-Medicine Limited develops, manufactures, and sells intermediates, active pharmaceutical ingredients (APIs), and finished dosage products in India and internationally. The company provides its APIs in a range of therapeutic areas, including anti depressant, anti hypertensive, anti fungal, anti diabetic, anti bacterial, anti Alzheimer, anti psychotic, anti protozoal, anti diarrhoeal, and cardiovascular areas, as well as veterinary, pro-kinetic, NSAID, and muscle relaxation areas. Its intermediate product line targets various API/end uses, such as ketoconazole, itraconazole, phase transfer catalyst, lansoprazole, trimetazidine, chemical synthesis, glibenclamide, glimepiride, amlodipine besylate, and sertraline HCL. The company also offers formulations in the therapeutic segments of oncology, antibiotics, dermatology, liquid orals, soft gelatin capsules, and suppositories. In addition, it provides clinical services, as well as various toxicology services related to animals. Sharon Bio-Medicine Limited was incorporated in 1989 and is based in Mumbai, India.
